|
CORTEX PHARM INC, (COR) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Cortex Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. The company develops a pharmacology that modulates AMPA-type glutamate receptors, a complex of proteins that is involved in communication between nerve cells in the human brain. The companys product family, AMPAKINE compounds, is used in correcting neurological and psychiatric diseases, as well as disorders that involve depressed functioning of pathways in the brain that use glutamate as a neurotransmitter. Cortex was organized in 1987 and is based in Irvine, California.
|
CORTEX PHARM INC Related |
|
Cortex Pharmaceuticals Developing drugs for the treatment of neurological disorders including Alzheimer's disease, schizophrenia, and depression.
|
|
COR: Profile for CORTEX PHARM INC - Yahoo! Finance See the company profile for CORTEX PHARM INC (COR) including business summary, industry/sector information, number of employees, business summary, corporate ...
|
|
COR: Summary for CORTEX PHARM INC - Yahoo! Finance Get detailed information on CORTEX PHARM INC (COR) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the ...
|
|
